Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel
· Delayed Price · Currency is ILS · Price in ILA 34.90
+0.30 (0.87%)
Feb 20, 2025, 5:24 PM IDT
TLV:CBI Revenue
Clal Biotechnology Industries had revenue of 32.00K ILS in the twelve months ending June 30, 2024, down -91.14% year-over-year. In the year 2023, Clal Biotechnology Industries had annual revenue of 104.00K, down -71.89%.
Revenue (ttm)
32.00K
Revenue Growth
-91.14%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
54.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 104.00K | -266.00K | -71.89% |
| Dec 31, 2022 | 370.00K | 146.00K | 65.18% |
| Dec 31, 2021 | 224.00K | 18.00K | 8.74% |
| Dec 31, 2020 | 206.00K | -113.09M | -99.82% |
| Dec 31, 2019 | 113.29M | 100.53M | 787.39% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 60.26B |
| Danel (Adir Yeoshua) | 2.71B |
| Kamada | 588.75M |
| Bait Bakfar | 102.08M |
| Novolog (Pharm-Up 1966) | 1.73B |
| Ilex Medical | 982.96M |
| BrainsWay | 143.60M |
| SofWave Medical | 210.53M |